Biomarkers that Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
- 27 June 2017
- journal article
- research article
- Published by Springer Nature in Current Colorectal Cancer Reports
- Vol. 13 (4) , 276-283
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- CEA – A Predictor for Pathologic Complete Response After Neoadjuvant Therapy for Rectal CancerDiseases of the Colon & Rectum, 2013
- Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgeryRadiation Oncology, 2013
- Impact of Interval between Neoadjuvant Chemoradiotherapy and TME for Locally Advanced Rectal Cancer on Pathologic Response and Oncologic OutcomeAnnals of Surgical Oncology, 2012
- Telomere-Specific Reverse Transcriptase (hTERT) and Cell-free RNA in Plasma as Predictors of Pathologic Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant ChemoradiotherapyAnnals of Surgical Oncology, 2012
- Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancerRadiation Oncology Journal, 2012
- Prospective study on the FDG–PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancerAnnals of Oncology, 2010
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJournal of Surgical Oncology, 2005
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002